Global Live Cell Imaging Market Research Report: Products (Equipment, Consumables, Software), Technology (Fluorescence Recovery After Photobleaching (FRAP), Others), Application (Drug Discovery, Cell Biology, Others), End-User – Global Forecast Till 2023

ID: MRFR/MED/4617-HCR | February 2021 | Region: Global | 100 pages

The global live cell imaging market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the global live cell imaging market is expected to grow at a CAGR ~9.0 % during the forecast period of 2018–2023., Live cell imaging is the technique to study live cells with the help of images obtained from imaging systems such as high content screening systems and microscopes. The increasing prevalence of chronic diseases and growing government funding in cell-based research are propelling the growth of this market. For instance, funding institutes such as Health Connexions, National Institute of Health, and W.M. Keck Foundation have granted funds to institutes such as Harvard School of Medicine, Perdue University, and Weldon School of Biomedical Engineering for the development of imaging technologies to be applied in the field of health, food, and environment. Furthermore, adoption of high content screening techniques in drug discovery and cell biology boosts the growth of the global live cell imaging market., However, the lack of availability of skilled professional and the high cost of high-content screening systems may hinder the growth of the market during the forecast period., The global live cell imaging market is currently dominated by many players. For instance, in April 2016, BioTek Instruments launched Lionheart FX, an automated live cell imager with augmented microscopy. Moreover, the company announced the collaboration with MilliporeSigma for long-term dynamic time-lapse analyses and live cell experiments. This collaboration involved the development of an integrated solution comprising MilliporeSigma's CellASIC ONIX2 Microfluidic system and BioTek's Lionheart FX Automated Live Cell Imager. , Research Methodology, Market Research Future research is conducted by industry experts who offer insight into industry structure, market segmentation, Treatment assessment, competitive landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments & categories geographically presented are studied and are estimated based on primary & secondary research., , Primary Resear

Market Scenario

Live cell imaging is the technique to study live cells with the help of images obtained from imaging systems such as high content screening systems and microscopes. The increasing prevalence of chronic diseases and growing government funding in cell-based research are propelling the growth of this market. For instance, funding institutes such as Health Connexions, National Institute of Health, and W.M. Keck Foundation have granted funds to institutes such as Harvard School of Medicine, Perdue University, and Weldon School of Biomedical Engineering for the development of imaging technologies to be applied in the field of health, food, and environment. Furthermore, adoption of high content screening techniques in drug discovery and cell biology boosts the growth of the global live cell imaging market.

However, the lack of availability of skilled professional and the high cost of high-content screening systems may hinder the growth of the market during the forecast period.

The global live cell imaging market is currently dominated by many players. For instance, in April 2016, BioTek Instruments launched Lionheart FX, an automated live cell imager with augmented microscopy. Moreover, the company announced the collaboration with MilliporeSigma for long-term dynamic time-lapse analyses and live cell experiments. This collaboration involved the development of an integrated solution comprising MilliporeSigma's CellASIC ONIX2 Microfluidic system and BioTek's Lionheart FX Automated Live Cell Imager.

Research Methodology

Market Research Future research is conducted by industry experts who offer insight into industry structure, market segmentation, Treatment assessment, competitive landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments & categories geographically presented are studied and are estimated based on primary & secondary research.

Primary Research

The extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with the key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of the major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.

Secondary Research

Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the global live cell imaging market. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, & developments related to the market and Treatment Perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, the international organization of chemical manufacturers, some paid databases and many others.

Key Players

Carl Zeiss AG (Germany), Leica Microsystems (Germany), Olympus Corporation (Japan), Sigma-Aldrich Corporation (U.S.), Nikon Corporation (Japan), Molecular Devices, LCC (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Danaher Corporation (U.S.), and BioTek Instruments (U.S.) are some prominent players in this market.

Segmentation

The global live cell imaging market is segmented on the basis of the product, technology, application, and end-user.

On the basis of product, the market is classified as equipment, consumables, and software. The equipment is further segmented as microscopes, standalone systems, cell analyzer, and image-capturing devices. The microscopes are further sub-segmented as conventional microscopes, confocal microscopes, and advanced fluorescence microscopes. The consumables are sub-segmented as assay kits, reagents, media, and others.

The global live cell imaging market on the basis of technology is segmented as fluorescence resonance energy transfer, fluorescence recovery after photobleaching, high-content analysis, ratiometric imaging, fluorescence in situ hybridization, total internal reflection fluorescence microscopy, multiphoton excitation microscopy and other technologies.

On the basis of application, the market is segmented into cell biology, stem cells, developmental biology, and drug discovery.

On the basis of end-user, the market is segmented as pharmaceutical companies, biotechnology companies, hospitals, diagnostic laboratories, and others.

Geographically, the global live cell imaging market has been segmented into America, Europe, Asia Pacific, and the Middle East and Africa. The American live cell imaging market is further segmented into North America and South America. North America is further classified as the U.S. and Canada.

The Europe live cell imaging market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, U.K., Italy, Spain, and Rest of Western Europe.

The Asia Pacific live cell imaging market is segmented into Japan, China, India, the Republic of Korea, Australia, and the Rest of Asia Pacific.

The Middle East & Africa live cell imaging market is segmented into the Middle East and Africa.

Regional Market Summary

Global Live Cell Imaging Market, by Region Market Share, 2017 (%)

Live Cell Imaging Market

Source: MRFR Analysis

The American region holds the major share of the global live cell imaging market, owing to the existing well-established healthcare system, increasing prevalence of cancer cases, and technological advancements. According to the report published by the American Cancer Society, 2017, around 190,500 of the estimated 600,920 cancer deaths in the United States are likely to be caused owing to cigarette smoking. Moreover, factors such as high capitalization in imaging systems as well as intensive research and development to improve the imaging quality and data functionality fuel the market growth in this region.

Europe holds the second position in the global live cell imaging market. It is expected that government support towards research & development expenditure and rising prevalence chronic diseases are likely to drive the European live cell imaging market. In addition, the presence of some key players such as Carl Zeiss AG, Leica Microsystems, and GE Healthcare in this region also facilitates the growth of this market. For instance, in November 2016, Carl Zeiss AG launched ZEISS celldiscover 7 automated microscope for live cell imaging. With this launch, the company expanded its product portfolio in live cell imaging.

The Asia Pacific live cell imaging market consists of countries, namely, China, Japan, the Republic of Korea, India, Australia, and the Rest of Asia Pacific. Japan is the largest market for live cell imaging due to an increase in the prevalence of cancer and demand for live cell imaging techniques. In China, factors responsible for the market growth are rising geriatric population with chronic diseases and availability of low-cost diagnostic and treatment options.

The Middle East & Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities.

Global Live Cell Imaging Market, by Product

Equipment

Microscopes

Conventional Microscopes

Confocal Microscopes

Advanced Fluorescence Microscopes

Standalone Systems

Cell Analyzers

Image-capturing Devices

Consumables

Assay Kits

Reagents

Media

Others

Software

Global Live Cell Imaging Market, by Technology

Fluorescence Recovery After Photobleaching (FRAP)

Fluorescence Resonance Energy Transfer (FRET)

High-content Analysis

Ratiometric Imaging

Fluorescence In Situ Hybridization (FISH)

Total Internal Reflection Fluorescence Microscopy (TRIF)

Multiphoton Excitation Microscopy (MPE)

Others

Global Live Cell Imaging Market, by Application

Cell Biology

Stem Cells

Developmental Biology

Drug Discovery

Global Live Cell Imaging Market, by End-user

Pharmaceutical Companies

Biotechnological Companies

Hospitals

Diagnostic Laboratories

Others

Global Live Cell Imaging Market, by Region

Americas

North America

U.S.

Canada

South America

Europe

Western Europe

Germany

France

Italy

Spain

U.K.

Rest of Western Europe

Eastern Europe

Asia Pacific

Japan

China

India

Australia

Republic of Korea

Rest of Asia Pacific

The Middle East & Africa

Middle East

Africa

Company Profiles

Carl Zeiss AG

Leica Microsystems

Nikon Corporation

Molecular Devices, LCC

PerkinElmer, Inc.

GE Healthcare

Becton, Dickinson, and Company

Olympus Corporation

Sigma-Aldrich Corporation

Thermo Fischer Scientific, Inc.

Danaher Corporation

BioTek Instruments

Intended Audience

Pharmaceutical Companies

Biotechnological Companies

Research and Development (R&D) Companies

Government Research Institutes

Academic Institutes and Universities

Frequently Asked Questions (FAQ) :

What would be the growth rate of the live cell imaging market during the forecast period of 2018 to 2023?

The live cell imaging market would record a CAGR of 9% during the forecast period of 2018 to 2023.

What could be detrimental to the live cell imaging market?

Lack of technical expertise and high cost of screening systems can prohibit the live cell imaging market from achieving expected growth.

Which country in the Asia Pacific is dominating the regional live cell imaging market?

Japan has the upper hand in the Asia Pacific live cell imaging market.

What factors would drive the North American live cell imaging market?

The North American live cell imaging market would get boosted by better research and development facilities, and a hike in investment plans for the market.

What end user industries are expected to boost the live cell imaging market?

The live cell imaging market would be bolstered by industries like biotechnology companies, pharmaceutical companies, diagnostic laboratories, hospitals, and others.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Live Cell Imaging Market, by Product

6.1 Introduction

6.2 Equipment

6.2.1 Microscopes

6.2.1.1 Conventional Microscopes